To include your compound in the COVID-19 Resource Center, submit it here.

Targeting pathogenic Th17 cells

How two new autoimmune targets drive pathogenic Th17 activity

A recent pair of studies offers two new approaches to treating autoimmune diseases that go after the source of Th17-mediated inflammation.

T helper type 17 (Th17) cells are effector T cells

Read the full 315 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers